01 1Cambrex Corporation
01 1ALPRAZOLAM
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-08-13
Pay. Date : 2013-08-02
DMF Number : 7094
Submission : 1987-08-04
Status : Active
Type : II
20
Cambrex Profarmaco Milano Srl, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Cambrex is an innovative life sciences company with a refreshingly human approach.
One of their notable products is ALPRAZOLAM, with a corresponding US DMF Number 7094.
Remarkably, this DMF maintains an Active status since its submission on August 04, 1987, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 13, 2013, and payment made on August 02, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
